Cited by 166Alzheimer's disease research and treatmentsCellular transport and secretionNeuroinflammation and Neurodegeneration Mechanisms

Role of Phosphatidylinositol Clathrin Assembly Lymphoid-Myeloid Leukemia (PICALM) in Intracellular Amyloid Precursor Protein (APP) Processing and Amyloid Plaque Pathogenesis

Open access
Xiao, Qingli, Gil, So-Chon, Yan, Ping, Wang, Yan, Han, Sharon, Gonzales, Ernie, Perez, Ronaldo, Cirrito, John R. +1 more·2012·Journal of Biological Chemistry

Abstract

One of the pathological hallmarks of Alzheimer disease is the accumulation of amyloid plaques in the extracellular space in the brain. Amyloid plaques are primarily composed of aggregated amyloid β peptide (Aβ), a proteolytic fragment of the transmembrane amyloid precursor protein (APP). For APP to be proteolytically cleaved into Aβ, it must be internalized into the cell and trafficked to endosomes where specific protease complexes can cleave APP. Several recent genome-wide association studies have reported that several single nucleotide polymorphisms (SNPs) in the phosphatidylinositol clathrin assembly lymphoid-myeloid leukemia (PICALM) gene were significantly associated with Alzheimer disease, suggesting a role in APP endocytosis and Aβ generation. Here, we show that PICALM co-localizes with APP in intracellular vesicles of N2a-APP cells after endocytosis is initiated. PICALM knockdown resulted in reduced APP internalization and Aβ generation. Conversely, PICALM overexpression increased APP internalization and Aβ production. In vivo, PICALM was found to be expressed in neurons and co-localized with APP throughout the cortex and hippocampus in APP/PS1 mice. PICALM expression was altered using AAV8 gene transfer of PICALM shRNA or PICALM cDNA into the hippocampus of 6-month-old APP/PS1 mice. PICALM knockdown decreased soluble and insoluble Aβ levels and amyloid plaque load in the hippocampus. Conversely, PICALM overexpression increased Aβ levels and amyloid plaque load. These…

Integrity signals

Registry

Crossref · 10.1074/jbc.m111.338376

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Reducing or overexpressing PICALM levels in hippocampal neurons of APP Swe; PSEN1 L166P mice with AAV8-mediated delivery of PICALM shRNA or cDNA indicated that PICALM might regulate Aβ production.

    “However, reducing or overexpressing PICALM levels in hippocampal neurons of APP Swe ; PSEN1 L166P mice with AAV8-mediated delivery of PICALM shRNA or cDNA, respectively, indicated that PICALM might regulate A 𝛃 production (658).”

    From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [658]

  • PICALM underexpression decreases levels of APP catabolites and reduces APP internalisation and Aβ generation.

    “PICALM underexpression decreases the levels of several APP catabolites, such as intracellular β-C-terminal fragment (β-CTF) and secreted sAPPβ, which has been attributed to its role in clathrin-mediated endocytosis [134].”
  • PICALM knockdown and overexpression respectively decreased and increased amyloid plaque loads in the hippocampi of 6-month-old APP/PS1 mice.

    “As opposed to BIN1 and CD2AP, PICALM knockdown and overexpression, respectively, decreased and increased amyloid plaque loads in the hippocampi of 6-month-old APP/PS1 mice [148].”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Xiao, Q., Gil, S.-C., Yan, P., Wang, Y., Han, S., Gonzales, E., Perez, R., Cirrito, J. R., & Lee, J.-M.
Affiliations
Washington University in St. Louis (US)
Corresponding author
Lee, Jin-Moo
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2012-06
Volume
287
Issue
25
Pages
21279-21289
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2046234674
Cited by
166
References
48
Citations by year
2026: 5 · 2025: 5 · 2024: 5 · 2023: 6 · 2022: 6 · 2021: 9 · 2020: 12 · 2019: 19 · 2018: 16 · 2017: 16 · 2016: 17 · 2015: 14 · 2014: 18 · 2013: 16 · 2012: 2
FWCI
9.46
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (submittedVersion)
  • PubMed Central (submittedVersion)
Funders
  • National Institute on Aging (K01 AG029524)
  • National Institute of Neurological Disorders and Stroke (P01 NS32636, R01 NS067905, R01 NS67905, P01 NS032636)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
PICALM, amyloid precursor protein, amyloid-beta, Alzheimer's disease, amyloid plaques, clathrin-mediated endocytosis, APP processing, APP/PS1 mice, hippocampus, shRNA knockdown, single nucleotide polymorphisms
MeSH terms
Alzheimer Disease, Amyloid, Animals, Clathrin, Hippocampus, Humans, Transduction, Genetic, Amyloid beta-Protein Precursor, Monomeric Clathrin Assembly Proteins, Cell Line, Tumor, Mice, Gene Knockdown Techniques, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review